Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by gbengaon Jan 02, 2020 10:56am

216 Views

Post# 30510911

RE:RE:Bubble is about to burst? Down to CAN $4.64 already!!!!!

May be. May be not. If you are even at this price, reduce your hold. Dont be greedy.

Pyritecubed wrote: IMO this is a coordinated pull back to allow for Institutional investors to accumulate at a lower entry in time for another run up when some inevitable news gets released.

GLTA

Bullboard Posts

The top 5 Canadian small-cap AI stocks